Bright Health Group Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

$BHG
Medical Specialities
Health Care
Get the next $BHG alert in real time by email
bhg-20240118
0001671284December 31false9250 NW 36th St Suite 420DoralFlorida00016712842024-01-182024-01-1800016712842024-01-012024-12-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported) January 18, 2024

NeueHealth, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-40537
47-4991296
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
9250 NW 36th St Suite 420, Doral, Florida
33178
Address of Principal Executive Office(Zip Code)
(612) 238-1321
Registrant's telephone number, including area code

Bright Health Group, Inc.
8000 Norman Center Drive Suite 900, Minneapolis, Minnesota
55437
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareBHGNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company




If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item 5.03    Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 18, 2024, we filed with the Secretary of State of the State of Delaware a Certificate of Amendment to our Ninth Amended and Restated Certificate of Incorporation to change our corporate name from Bright Health Group, Inc. to NeueHealth, Inc. A copy of the Certificate of Amendment to the Ninth Amended and Restated Certificate of Incorporation is attached as Exhibit 3.1 hereto and incorporated by reference.

In connection with our name change, our board of directors amended and restated our Bylaws to reflect the corporate name NeueHealth, Inc. No other changes were made to our Bylaws. A copy of the Fourth Amended and Restated Bylaws reflecting the new name is attached as Exhibit 3.2 hereto and incorporated by reference.

Our common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock Exchange, effective January 29, 2024. Outstanding stock certificates for shares of the Company are not affected by the name change; they continue to be valid and need not be exchanged.


Item 9.01    Financial Statements and Exhibits.

(d) Exhibits.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NeueHealth, Inc.
Date:January 24, 2024By:/s/ Jeff Craig
Name:Jeff Craig
Title:General Counsel and Corporate Secretary


Get the next $BHG alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BHG

DatePrice TargetRatingAnalyst
10/11/2022Neutral → Underweight
JP Morgan
3/29/2022Overweight → Neutral
JP Morgan
3/4/2022$9.00 → $3.00Outperform → Sector Perform
RBC Capital
3/3/2022$4.00 → $2.00Underweight
Morgan Stanley
3/3/2022$5.00 → $3.50Neutral
Goldman Sachs
3/3/2022$5.50 → $4.00Overweight
Barclays
3/3/2022$10.00 → $5.00Overweight
Piper Sandler
3/2/2022Buy → Underperform
BofA Securities
More analyst ratings

$BHG
Press Releases

Fastest customizable press release news feed in the world

See more
  • Bright Health Group Adopts NeueHealth as Corporate Brand Name

    The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock

    $BHG
    Medical Specialities
    Health Care
  • Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare

    Completes final repayment on secured credit facility eliminating the Company's secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare, Inc. ("Molina"). The sale closed, effective as of Januar

    $BHG
    Medical Specialities
    Health Care
  • Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

    Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company's secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider enablement business Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final

    $BHG
    Medical Specialities
    Health Care

$BHG
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$BHG
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$BHG
Leadership Updates

Live Leadership Updates

See more
  • Bright Health Group Appoints Jay Matushak as Chief Financial Officer

    Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company's next Chief Financial Officer, effective May 12, 2023. Mr. Matushak will succeed Cathy Smith, who is stepping down to pursue another opportunity. Mr. Matushak, a seasoned finance and operational executive with deep expertise in the healthcare business, joined Bright Health in 2021. He currently serves as Senior Vice President of Finance and is responsible

    $BHG
    Medical Specialities
    Health Care
  • Bright Health Group Announces Retirement of General Counsel Keith Nelsen

    Jeff Craig, lead counsel for the Company's NeueHealth business, named General Counsel and Corporate Secretary Bright Health Group, Inc. ("Bright Health" or "The Company") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that Keith Nelsen will retire as General Counsel and Corporate Secretary. Jeff Craig, lead counsel for the Company's NeueHealth business, will be promoted to the role of General Counsel and Corporate Secretary effective March 18, 2022. Nelsen will stay on as a senior advisor with the Company until June 30, 2022, to ensure a smooth transition. "Keith has been a key leader for many of our mi

    $BHG
    Medical Specialities
    Health Care
  • Bright Health Group Names Leading Healthcare Expert to Board

    Matthew Manders to Join as Independent Director Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that leading healthcare expert Matt Manders will join the company's Board as an independent director, effective March 1. Manders brings a wealth of diverse healthcare experience, focus on operational excellence, and expertise in consumer-driven healthcare. Most recently, he served as president of Cigna Corporation's Government and Solutions organization, part of a 30-plus-year career with the company. In this role, Manders led and managed Cigna's U.S. Government busi

    $BHG
    Medical Specialities
    Health Care

$BHG
Financials

Live finance-specific insights

See more
  • Bright Health Group Reports Third Quarter 2023 Results

    Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r

    $BHG
    Medical Specialities
    Health Care
  • Bright Health Group to Host Third Quarter 2023 Earnings Conference Call on November 7, 2023

    Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe

    $BHG
    Medical Specialities
    Health Care
  • Bright Health Group Reports Second Quarter 2023 Results

    Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi

    $BHG
    Medical Specialities
    Health Care

$BHG
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more